Cryofocus Medtech (Shanghai) Past Earnings Performance
Past criteria checks 0/6
Key information
7.9%
Earnings growth rate
17.2%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 36.3% |
| Return on equity | -61.0% |
| Net Margin | -238.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Cryofocus Medtech (Shanghai) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 41 | -97 | 75 | 76 |
| 30 Jun 23 | 36 | -113 | 88 | 71 |
| 31 Mar 23 | 31 | -113 | 88 | 66 |
| 31 Dec 22 | 27 | -112 | 88 | 60 |
| 31 Dec 21 | 22 | -102 | 56 | 39 |
| 31 Dec 20 | 9 | -137 | 127 | 42 |
Growing Profit Margin: 6922 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 6922's year-on-year earnings growth rate was positive over the past 5 years.